Fri, November 11, 2016
Thu, November 10, 2016

Matthew Luchini Initiated (BLUE) at Hold and Held Target at $61 on, Nov 11th, 2016

Matthew Luchini of BMO Capital, Initiated "bluebird bio, Inc." (BLUE) at Hold and Held Target at $61 on, Nov 11th, 2016.

Matthew has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $100 on, Thursday, September 29th, 2016
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy and Held Target at $135 on, Thursday, September 15th, 2016